172 related articles for article (PubMed ID: 2768132)
1. Establishment of five human myeloma cell lines.
Namba M; Ohtsuki T; Mori M; Togawa A; Wada H; Sugihara T; Yawata Y; Kimoto T
In Vitro Cell Dev Biol; 1989 Aug; 25(8):723-9. PubMed ID: 2768132
[TBL] [Abstract][Full Text] [Related]
2. [Establishment and characterization of five human myeloma cell lines].
Ohtsuki T; Yawata Y; Namba M
Hum Cell; 1989 Sep; 2(3):297-303. PubMed ID: 2519219
[TBL] [Abstract][Full Text] [Related]
3. Cellular biological differences between human myeloma cell lines KMS-12-PE and KMS-12-BM established from a single patient.
Otsuki T; Hata H; Harada N; Matsuzaki H; Yata K; Wada H; Yawata Y; Ueki A; Yamada O
Int J Hematol; 2000 Aug; 72(2):216-22. PubMed ID: 11039672
[TBL] [Abstract][Full Text] [Related]
4. Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).
Ohtsuki T; Yawata Y; Wada H; Sugihara T; Mori M; Namba M
Br J Haematol; 1989 Oct; 73(2):199-204. PubMed ID: 2479409
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia.
Otsuki T; Nakazawa N; Taniwaki M; Yamada O; Sakaguchi H; Wada H; Yawata Y; Ueki A
Int J Oncol; 1998 Mar; 12(3):545-52. PubMed ID: 9472091
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.
Hata H; Matsuzaki H; Matsuno F; Sonoki T; Takemoto S; Kuribayashi N; Nagasaki A; Takatsuki K
Clin Exp Immunol; 1994 May; 96(2):370-5. PubMed ID: 8187346
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of suramin on human cancer cells in vitro and in vivo.
Bai L; Naomoto Y; Miyazaki M; Orita K; Namba M
Acta Med Okayama; 1992 Dec; 46(6):457-63. PubMed ID: 1485540
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous expression of a novel MPC-1 antigen on myeloma cells: possible involvement of MPC-1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells.
Huang N; Kawano MM; Harada H; Harada Y; Sakai A; Kuramoto A; Niwa O
Blood; 1993 Dec; 82(12):3721-9. PubMed ID: 8260709
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Miyamoto K; Hyodo H; Namba M
Int J Cancer; 1982 May; 29(5):495-500. PubMed ID: 7095894
[TBL] [Abstract][Full Text] [Related]
10. Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14).
Otsuki T; Wada H; Nakazawa N; Taniwaki M; Kouguchi K; Ohkura M; Uehira K; Isoda K; Yata K; Sakaguchi H; Yawata Y; Ueki A; Yamada O
Leuk Lymphoma; 2001 Aug; 42(4):761-74. PubMed ID: 11697507
[TBL] [Abstract][Full Text] [Related]
11. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Mannoji M; Namba M
Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
[TBL] [Abstract][Full Text] [Related]
12. Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996).
Jernberg H; Nilsson K; Zech L; Lutz D; Nowotny H; Scheirer W
Blood; 1987 Jun; 69(6):1605-12. PubMed ID: 3580570
[TBL] [Abstract][Full Text] [Related]
13. Cell growth kinetics of cultured human myeloma cell lines, KMM-1 and KMS-5.
Ohtsuki T; Yawata Y; Namba M
Nihon Ketsueki Gakkai Zasshi; 1988 Sep; 51(6):1052-8. PubMed ID: 3201898
[No Abstract] [Full Text] [Related]
14. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Nakazawa N; Taniwaki M; Yawata Y; Ueki A
Int J Oncol; 1999 Dec; 15(6):1205-12. PubMed ID: 10568829
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of four myeloma cell lines which are responsive to interleukin-6 for their growth.
Okuno Y; Takahashi T; Suzuki A; Ichiba S; Nakamura K; Fukumoto M; Okada T; Okada H; Imura H
Leukemia; 1991 Jul; 5(7):585-91. PubMed ID: 2072743
[TBL] [Abstract][Full Text] [Related]
16. Effect of the nitrosourea anti-tumor chemotherapeutical agent MCNU on five human myeloma cell lines.
Otsuki T; Sakaguchi H; Yamada O; Yawata Y; Ueki A
Oncol Rep; 1998; 5(4):827-32. PubMed ID: 9625826
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of two human myeloma cell lines secreting kappa light chains.
Eton O; Scheinberg DA; Houghton AN
Leukemia; 1989 Oct; 3(10):729-35. PubMed ID: 2506399
[TBL] [Abstract][Full Text] [Related]
18. Two distinct human myeloma cell lines originating from one patient with myeloma.
Katagiri S; Yonezawa T; Kuyama J; Kanayama Y; Nishida K; Abe T; Tamaki T; Ohnishi M; Tarui S
Int J Cancer; 1985 Aug; 36(2):241-6. PubMed ID: 3926660
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene.
Gazdar AF; Oie HK; Kirsch IR; Hollis GF
Blood; 1986 Jun; 67(6):1542-9. PubMed ID: 2423157
[TBL] [Abstract][Full Text] [Related]
20. Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice.
Tong AW; Huang YW; Zhang BQ; Netto G; Vitetta ES; Stone MJ
Anticancer Res; 1993; 13(3):593-7. PubMed ID: 8391243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
